EasyNAT® Novel-Coronavirus (2019-nCoV) Real-Time Molecular Diagnostic System

EasyNAT®

Multi-module POCT system that integrates with the process of nucleic acid extraction, amplification and detection in one equipment.

Description

The EasyNAT® System is based on three-stage magnetic conductivity extraction technology and patented Cross Priming Amplification Technology. The system is available in a 2, 4, 8or 16-module configuration and use the patented reagent vitrification technology for every EasyNAT test.

 

Core Technologies

  • Cross Priming Isothermal Amplification Technology (CPA)
  • Reagent Vitrification Technology

 
Advantages

  • Accurate: High-sensitivity,High-specificity,LoD: 200 copies/mL
  • Faster:49 minutes “samples in result out” for SARS-CoV-2 diagnosis
  • POCT: Automatic integration of nucleic acid extraction, amplification and detection
  • Safe:Patented cartridge design,Closed testing,No cross-contamination
  • Simple: One-button operation
  • Easy transportation: Vitrified preloaded cartridge,Ambient temperature transportation (-25℃-30℃)

 

Read more at manufacturer’s homepage.